SCHEMBL13869002

SCHEMBL13869002

Cc1cc(Nc2ncccc2C(=O)O)n(C)n1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.56
GAA P10253 1/20 0.56
MEN1 O00255 6/20 0.55
KMT2A Q03164 6/20 0.55
RAB9A P51151 4/20 0.55
NPC1 O15118 3/20 0.55
MAPT P10636 1/20 0.55
DHODH Q02127 10/20 0.54
HTT P42858 3/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
PKM P14618 2/20 0.49
ALDH1A1 P00352 2/20 0.49
MAPK1 P28482 1/20 0.49
CLCN2 P51788 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
HDAC6 Q9UBN7 1/20 0.47
GMNN O75496 1/20 0.46
TTR P02766 1/20 0.46
CYP1A2 P05177 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3978991 0.84 GFER (0.57) LMNAGAAMEN1KMT2ARAB9A
SCHEMBL3974243 0.84 DHODH (0.50) LMNAGAAMEN1KMT2ARAB9A
SCHEMBL6341341 0.82 MEN1 (0.54) LMNAGAAMEN1KMT2ARAB9A
SCHEMBL13869101 0.80 MAPT (0.44) LMNAGAAMEN1KMT2ARAB9A
SCHEMBL5253749 0.80 GFER (0.61) LMNAMEN1KMT2AMAPTSMN1; SMN2
SCHEMBL5310758 0.77 SMN1; SMN2 (0.46) LMNAGAAMEN1KMT2AMAPT
SCHEMBL3973229 0.74 NTRK1 (0.54) LMNAGAAKMT2ARAB9ANPC1
SCHEMBL5469997 0.73 SMN1; SMN2 (0.47) MEN1KMT2AMAPTDHODHHTT
SCHEMBL11707284 0.73 CLCN2 (0.47) MEN1KMT2AMAPTHTTSMN1; SMN2
SCHEMBL5005305 0.73 TAS2R14 (0.46) MEN1KMT2AMAPTDHODHHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7517878-B2 Heteroarylaminopyrazole derivatives useful for the treatment of diabetes BAYER PHARAMCEUTICALS CORPORATION (US) 2009-04-14 US disclosed
US-7517878-B2 Heteroarylaminopyrazole derivatives useful for the treatment of diabetes BAYER PHARAMCEUTICALS CORPORATION (US) 2009-04-14 US disclosed